CASP9 and Parkinson disease: Moreover, in a Parkinson’s disease mouse model, decreased intraneuronal a synuclein aggregation was reported following miR-29c induced inhibition of pro-inflammatory cytokines production and caspase-3 and caspase-9 expression (41).